Keywords
Menopausa
Eficacia
Segurança
Osteoporose
Doenças Cardiovasculares
How to Cite
Abstract
This article provides a comprehensive review of Hormone Replacement Therapy (HRT) in menopause, focusing on its efficacy and safety. We evaluate different types of interventions, including the combination of estrogen and progestogen and the use of estrogen alone, as well as the impact of HRT on specific populations, including women at high risk for osteoporosis and those with preexisting cardiovascular conditions. The findings indicate that HRT is effective in relieving menopausal symptoms and preventing osteoporosis, but its use must be carefully assessed due to potential associated risks, such as breast cancer and cardiovascular diseases. The review emphasizes the importance of an individualized approach, considering factors such as age, health history, and timing of therapy initiation.
References
Anderson, G. L., et al. (2004). Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. Journal of the American Medical Association, 291(14), 1701-1712.
Cauley, J. A., et al. (2003). Estrogen plus progestin and the risk of coronary heart disease. New England Journal of Medicine, 349(6), 523-534.
Chlebowski, R. T., et al. (2003). Breast cancer after use of estrogen plus progestin in postmenopausal women. New England Journal of Medicine, 349(6), 523-534.
Cummings, S. R., et al. (1995). Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. New England Journal of Medicine, 333(22), 1437-1443.
Delmas, P. D., et al. (2002). Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: Four-year results from a randomized clinical trial. Journal of Clinical Endocrinology & Metabolism, 87(8), 3609-3617.
Ettinger, B., et al. (1999). Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: Results from a 3-year randomized clinical trial. Journal of the American Medical Association, 282(7), 637-645.
Greendale, G. A., et al. (2021). Hormone therapy for the primary prevention of chronic conditions in postmenopausal women: US Preventive Services Task Force Recommendation Statement. JAMA, 325(9), 867-880.
Grodstein, F., et al. (2006). Hormone therapy and coronary heart disease: The role of time since menopause and age at hormone initiation. Journal of Women's Health, 15(1), 35-44.
Herrington, D. M., et al. (2000). Effects of estrogen replacement on the progression of coronary-artery atherosclerosis. New England Journal of Medicine, 343(8), 522-529.
Hodis, H. N., et al. (2016). Vascular effects of early versus late postmenopausal treatment with estradiol. New England Journal of Medicine, 374(13), 1221-1231.
Hsia, J., et al. (2006). Conjugated equine estrogens and coronary heart disease: The Women's Health Initiative. Archives of Internal Medicine, 166(3), 357-365.
Hulley, S., et al. (1998). Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Journal of the American Medical Association, 280(7), 605-613.
Manson, J. E., et al. (2013). Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women’s Health Initiative randomized trials. Journal of the American Medical Association, 310(13), 1353-1368.
Riggs, B. L., et al. (2002). Effect of estrogen and estrogen/progestin regimens on bone mineral density in postmenopausal women. Journal of Bone and Mineral Research, 17(4), 746-753.
Rossouw, J. E., et al. (2002). Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. Journal of the American Medical Association, 288(3), 321-333.
Shoupe, D., et al. (2004). Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women. Journal of the American Medical Association, 291(14), 1701-1712.
Stefanick, M. L., et al. (2006). Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy. Journal of the American Medical Association, 295(14), 1647-1657.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2024 José kenedy santiago Sousa , Albion de Barros Curado Neto , Willian Arthur Fidelis dos Santos , Alanna Sohl Marcell da Silva Carmo , João Maurício Vicente Madureira, Wesley Rodrigues Louro, Naomi Vallada Kitayama, Luiza Higino Cruz, Bruna Frizzo Salvador, Bruno Moreira Brito , Rafael Ferreira Pereira, Marthone Glauberg Leandro de Freitas Rodrigues, Simone da Costa Silva